ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Telmisartan+HCTZ, Hypertension

This study has been completed.
Study NCT00659607.   Last updated on November 18, 2008.   Information provided by Boehringer Ingelheim Pharmaceuticals
Please refer to this study by its ClinicalTrials.gov identifier: NCT00659607


Locations
Korea, Republic of
Boehringer Ingelheim    
      Busan, Korea, Republic of
Boehringer Ingelheim    
      Seoul, Korea, Republic of
Boehringer Ingelheim    
      Gyeonggido, Korea, Republic of
Boehringer Ingelheim    
      Gwangju, Korea, Republic of
Boehringer Ingelheim    
      Daegu, Korea, Republic of
Boehringer Ingelheim    
      Daejeon, Korea, Republic of
Boehringer Ingelheim    
      Chungnam, Korea, Republic of
Boehringer Ingelheim    
      Incheon, Korea, Republic of
Boehringer Ingelheim    
      Jeju, Korea, Republic of
Boehringer Ingelheim    
      Jeonnam, Korea, Republic of
Boehringer Ingelheim    
      Jeonbuk, Korea, Republic of
Boehringer Ingelheim    
      Ulsan, Korea, Republic of
Boehringer Ingelheim    
      Gangwondo, Korea, Republic of

Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals

Investigators
Study Chair:     Boehringer Ingelheim Study Coordinator     B.I. Korea Ltd.    





Links to all studies - primarily for crawlers